|
|
Virtual Patient: Adult Male with Reaction to Flying Hymenoptera Sting
This patient simulation involves an adult male who had a severe reaction to a flying hymenoptera sting. Based on the clinical history and test results, the learner will choose the best way to treat the patient with immunotherapy. The learner will answer specific questions that explain the immunotherapy treatment, including risks, intervals, duration, and possibility of relapse to the patient. The learner will receive feedback for each decision that is made, and numerous references that discuss... |
|
|
Long-Acting Injectables for Schizophrenia: An Effective, Yet Often Underutilized Tool for Rapid Symptom Reduction and Restoration of Function
Schizophrenia is a serious and debilitating disorder that often poses a considerable challenge to clinicians. While long-acting injectables (LAIs) have emerged as a viable means to address patient nonadherence – often a component of schizophrenia management – clinicians often fail to implement the use of LAIs. Many times this is due to clinicians not being aware of updates such as the introduction of LAIs with increased dosing intervals, knowledge that is an important aspect of narrowing p... |
|
|
Recent Clinical Trial Data on the Safety and Efficacy of Current and Emerging Therapies to Optimize Schizophrenia Management
Safe and effective treatments for schizophrenia are imperative to optimizing personalized therapy, which helps in reducing relapse and promoting functional recovery in patients with schizophrenia. Emerging data on reducing symptoms, maintaining effective therapy over long-term periods, and minimizing treatment-related metabolic side effects can guide clinicians in choosing the best therapies for their patients. In the final episode of the CMEOcast podcast series on schizophrenia, expert facult... |
|
Multiple Myeloma: Enhancing Treatment Tolerability, Adherence, and Patient-Centered Care
STATEMENT OF NEED
Multiple myeloma (MM) is a B-cell neoplasm characterized by aberrant expansion of plasma cells within the bone marrow and extramedullary sites (eg, cortical bone). Approximately 32,270 new cases of MM are diagnosed in the United States annually and 12,830 people die of the disease. Although the tumor cells remain primarily within the bone marrow, they can cause a number of complications, including localized bone destruction, anemia, decreased immunity to infection, and kid... |
|
|
Shaping the Future of Myeloma Treatment
To help hematologist-oncologists keep pace with new advancements in multiple myeloma therapeutic regimens and management strategies, Shaping the Future of Myeloma Treatment features a roundtable discussion in which a panel of myeloma experts addresses a number of key clinical topics. Learners who participate in these activities will be expected to improve their ability to individualize treatment plans, based on genomics and risk stratification, to achieve durable remission while minimizing tox... |
|
|
Eradication of Minimal Residual Disease in Multiple Myeloma: The Role and Timing of ASCT
Advances in multiple myeloma (MM) management have equipped oncology health care providers with the tools and strategies for achieving treatment responses in up to 100% of patients, with as many as 80% reaching a complete response (CR). However, achieving a CR does not always predict long-term survival, and most patients ultimately relapse as a result of the persistence of minimal residual disease (MRD) after treatment. MRD cannot be detected with conventional, low-sensitivity evaluation method... |
|
|
Current Obstacles in Myeloma Management: Debating the Evidence
ACTIVITY DESCRIPTION
The clinical multiple myeloma arena has seen significant advances in treatment, diagnosis, imaging, disease monitoring, and supportive care. The approval of several new agents has led to expanded criteria for earlier-stage diagnosis in some higher-risk patients with smoldering multiple myeloma (SMM), though questions remain regarding optimal treatment of other SMM patients. Treatment advances have improved median survival; nevertheless, prognosis remains poor for some pat... |
|
|
Quelling an Internal Civil War: New and Emerging Treatments for Graft-vs-Host Disease
Target Audience
This educational activity has been designed for hematologists/oncologists, oncology and hematology fellows, and other members of the oncology care team who need to be aware of recent and emerging advances the prevention and treatment of GvHD.
Statement of Need/Program Overview
The leading cause of non-relapse post- allogeneic hematopoietic stem cell transplant mortality is GvHD manifesting as immunobiological warfare waged by the donor cells against multiple organ systems ... |
|
|
MCL Patient Exam in the Era of Targeted Therapies: Workup, Prognosis, Treatment, and Monitoring
The rapid evolution of treatment advances in mantle cell lymphoma (MCL) make treatment a complex and challenging proposition. Though several randomized, controlled trials on the use of targeted agents in MCL have been conducted, there are limited published, randomized data providing definitive guidance on treatment selection, duration of treatment, management of treatment-related toxicities, and disease outcomes across different lines of therapy.
This activity has been developed to help cl... |
|
|
Staying Up to Date with Advances in the Management of Multiple Sclerosis
Early diagnosis is key to improving outcomes in patients with multiple sclerosis (MS). Initiating disease-modifying therapy (DMT) as soon as possible is important in controlling disease symptoms, mitigating disease progression/preventing relapse, and minimizing disease-related disability. A deeper understanding of the pathophysiology of MS has revolutionized the DMT landscape, offering patients 16 approved therapies. However, difficulties ensuring an accurate diagnosis and clinical uncertainti... |
|
|
RME Hot Seat: Prognosis, Treatment Choice, and Risk Management for CLL and MCL
With the emergence of new targeted therapies and new prognostic indicators and goals of treatment, the clinical management of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL)—for patients in the frontline and relapsed/refractory settings—has evolved significantly.
In this Q&A-based activity, our experts provide practical, evidence-based answers to questions relating to several of the most consequential changes in CLL/MCL patient care, including diagnostic and prognostic... |
|
|
Acute Myeloid Leukemia: What’s New on the Horizon
Rapid progress in the treatment of Acute Myeloid Leukemia (AML) has resulted in a substantial volume of new clinical literature and updated guidelines. 8 new therapies have been approved since 2017 alone. Clinicians must remain well-versed with novel treatment options for newly diagnosed patients and those with relapsed/refractory AML and need education on advances in targeted therapies for AML.
This expert live recording from a series of national visiting lecture series updates clinicians ... |
|
|
Eosinophilic Granulomatosis with Polyangiitis: Where Are We with Diagnosis and Management?
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare disseminating vasculitis that has a heterogeneous presentation. Because of this and its infrequent occurrence, it is often not considered in the differential diagnosis of patients presenting with vasculitis. Diagnosis is further complicated by the lack of diagnostic criteria, causing most patients to experience diagnostic delays. In addition, there is little in the way of guidance for rheumatologists with respect to managing EGPA. ... |
|
|
Strategies for Neuroprotection, Relapse Prevention, and Mortality Reduction in Patients with Schizophrenia
Target Audience
This education activity is directed towards OB-GYNs, medical oncologists, surgical oncologists, radiation oncologists, primary care physicians, such as family practitioners and internists, and radiologists.
Program Overview
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare T-cell lymphoma and is a distinct entity from systemic ALCL. In the United States, the FDA began to recognize reports of ALCL and a potential association with breast impla... |
|
|
Strategies for Neuroprotection, Relapse Prevention, and Mortality Reduction in Patients with Schizophrenia
Only a minority of patients with schizophrenia consistently adhere to their oral antipsychotics. Long-acting injectable (LAI) formulations of antipsychotics improve patient outcomes through both neuroprotection and improved adherence. To ensure that more patients with schizophrenia are offered the opportunity to take LAIs, clinicians who provide psychiatric care must possess accurate information about this important treatment option. In this activity, an expert faculty member will discuss the ... |
|
|
Strategies for Neuroprotection, Relapse Prevention, and Mortality Reduction in Patients with Schizophrenia
Target Audience
This activity has been designed to meet the educational needs of psychiatrists and advanced practice psychiatric clinicians who care for patients with schizophrenia.
Program Overview
Only a minority of patients with schizophrenia consistently adhere to their oral antipsychotics. Long-acting injectable (LAI) formulations of antipsychotics improve patient outcomes through both neuroprotection and improved adherence. To ensure that more patients with schizophrenia are off... |
|
|
Finding Feeling: Treating Traumatic Dissociation
Trauma is a both a physical and psychological disruption, a discontinuity in experience. The helplessness associated with it challenges a person’s sense of agency and therefore their customary control over mind and body. Dissociative disorders constitute a failure of integration of identity, memory, or consciousness, andmost often occur in the aftermath of trauma. A Dissociative Subtype has been added to the diagnosis of Post-Traumatic Stress Disorder the DSM-5. This requires all of the DSM-... |
|
|
A 4-Year Prospective Study of Eating Disorder NOS
To examine the course of Eating Disorder NOS (EDNOS) compared with anorexia nervosa (AN), bulimia nervosa (BN) and binge eating disorder (BED). Method: Prospective study of 385 participants meeting DSM-IV criteria for AN, BN, BED and EDNOS at 3 sites. Recruitment was from the community and specialty clinics. Participants were followed at 6-month intervals over a 4-year period using the Eating Disorder Examination as the primary assessment. Results: EDNOS remitted significantly more quickly tha... |
|
|
Separation Anxiety in Children & Adolescents
This CE test is based on the book "Separation Anxiety in Children & Adolescents" (2005, 298 pages). The book presents a research-based approach to understanding the challenges of separation anxiety and helping children, adolescents, and their parents build the skills they need to overcome it. The authors provide step-by-step guidelines for implementing the entire process of therapy-from intake and assessment through coping skills training, cognitive-behavioral interventions, and relapse preven... |
|
|
Substance Abuse and Dependency
Target audience: Social Workers, Psychologists, Counselors, Marriage & Family Therapists, Addiction Counselors
This course looks at the assessment and treatment of a variety of drug and alcohol related issues as well as an in-depth look at the behavioral and physiological effects of some of the most commonly abused drugs.
Reading of the books, "Treating Alcohol and Drug Problems in Psychotherapy Practice" and "Buzzed: The Straight Facts about the Most Used and Abused Drugs from Alcohol t... |
|
|
Substance Abuse Treatment: Addressing the Specific Needs of Women
Target Audience: Social Workers, Psychologists, Counselors, Marriage & Family Therapists, Addiction Counselors
Course Syllabus:
* Introduction
* Patterns of Use: From Initiation to Treatment
* Substance Use and Birth Outcomes
* Culturally Responsive Screening and Assessment
* The Impact of Trauma and Prenatal Care
* Substance Abuse Among Specific Population Groups
* Relational Model Approach
* Postpartum Relapse Prevention |
|
|
Tobacco use and mental illness
Overview of contributing factors to the increased use of tobacco amongst individuals with mental illness.
Target audience: Social Workers, Psychologists, Counselors, Marriage & Family Therapists, Addiction Counselors
Syllabus:
* Tobacco use & mental illness
* Assessment & intervention
* Smoking cessation
* Relapse prevention
Unlimited Access to Over 200 Courses
Starting at Only $74.99 |
|
|
Introduction and Overview (Section I); and The Older Adult Treatment Population (Section II): From Substance Abuse Relapse Prevention for Older Adults--A Group Treatment Approach
I. Introduction and Overview: From Substance Abuse Relapse Prevention for Older Adults—A Group Treatment Approach provides background and how-to directions for introducing relapse techniques to older clients.
II. The Older Adult Treatment Population: From Substance Abuse Relapse Prevention for Older Adults—A Group Treatment Approach provides an overview of the target population for cognitive-behavioral and self-management intervention (CB/SM) for older adults who have substance use diso... |
|
|
Codependency: Causes, Consequences and Cures
In this course, the author offers in-depth and in-person strategies for therapists to use in working with clients who present with the characteristic behavior patterns of codependency. Clients are usually unaware of the underlying codependency that is often responsible for the symptoms they’re suffering. Starting with emphasis on the delicate process of building a caring therapeutic relationship with these clients, the author guides readers through the early shame-inducing parenting styles t... |
|